The first reports of CRB2-associated steroid-resistant nephrotic syndrome (SRNS) emerged in 2015, when Slavotinek et al. described six patients from three families exhibiting nephrosis, ventriculomegaly, and elevated alpha-fetoprotein levels, with prenatal manifestations being a hallmark. This evidence concerns the gene CRB2 and nephrosis.